Vanguard CPV-L: Presentation
|
Vanguard CPV-L
Presentation
A solution for injection, each 1ml dose containing live attenuated canine parvovirus, NL-35-D strain, low passage ≥ 107.0 CCID50, inactivated Leptospira canicola ≥ PD40 and inactivated Leptospira icterohaemorrhagiae ≥ PD40.
|
 |
 
        |
 |
|
|
|
|||||||||||||||||||||||||
Date updated: 28 September 2006